Clinical Trials Sponsored by Boehringer Ingelheim

Total 2354 results

Boehringer Ingelheim

Not yet recruiting

Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With Advanced Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment

Lung Cancer, Non-squamous, Non-small Cell
Boehringer Ingelheim

Not yet recruiting

A Study in Healthy Men to Test How Well Different Doses of BI 1584862 Are Tolerated

Healthy
Boehringer Ingelheim

Not yet recruiting

A Study to Test Whether BI 765845 Helps People Who Have Had an Acute Heart Attack

Myocardial Infarction
Boehringer Ingelheim

Not yet recruiting

A Study to Test How Different Doses of BI 1015550 Are Taken up in the Body of Healthy Japanese Men

Healthy
Franciscus Gasthuis

Not yet recruiting

Screening Adults With Obesity to Reduce Heart Failure Events (SCOR(hf)E)

Heart Failure | Obesity
Click Therapeutics, Inc.

Recruiting

A Study to Evaluate the Overall Effects of Treatment With Abbreviated CT-156 in People With Schizophrenia

Schizophrenia

United States
Boehringer Ingelheim

Not yet recruiting

DAREON™-7: A Study to Test How Well Different Doses of BI 764532 in Addition to Chemotherapy Are Tolerated by People With Advanced Neuroendocrine Cancers

Neuroendocrine Neoplasms
Boehringer Ingelheim

Not yet recruiting

Real-world Study of Dedifferentiated Liposarcoma Patients in China

Dedifferentiated Liposarcoma

China
Boehringer Ingelheim

Not yet recruiting

A Study in Healthy People to Test Whether Different Doses of BI 1015550 Have Potential to Induce Heart Rhythm Abnormalities

Healthy
University Medical Center Groningen

Not yet recruiting

Treatment Optimization for Patients With Type 2 Diabetes Using Empagliflozin and Finerenone in a Remote Clinical Trial (Optimize@Home)

Diabetes Mellitus, Type 2 | Diabetes Mellitus | Diabetes | Diabetes Complications | Chronic Kidney Diseases | Albuminuria | CKD | Chronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | CKD Stage 4 ...
Icahn School of Medicine at Mount Sinai

Recruiting

Spesolimab in Pyoderma Gangrenosum

Pyoderma Gangrenosum

United States
Boehringer Ingelheim

Not yet recruiting

A Study to Test Different Doses of BI 765049 Alone and in Combination With Ezabenlimab in Asian People With Advanced Cancer (Solid Tumours) Positive for B7-H6

Head and Neck Cancer | Colorectal Cancer | Pancreatic Cancer | Lung Cancer | Gastrointestinal Cancer | Liver Cancer
Institut Bergonié

Not yet recruiting

Targeting MDMD and PD1 in Tumors With Tertiary Lymphoid Structures (EMPIRE)

Colorectal Cancer | Non Small Cell Lung Cancer | Triple Negative Breast Cancer | Biliary Tract Cancer | Adult Soft Tissue Sarcoma

France
Boehringer Ingelheim

Recruiting

A Study in Healthy Men to Test How Well Different Doses of BI 3802876 Are Tolerated

Healthy

Belgium
Boehringer Ingelheim

Not yet recruiting

A Study to Test Whether BI 685509 Helps People With Liver Cirrhosis and High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver) Who Had Bleeding in the Esophagus or Fluid Accumulation in the Belly

Liver Cirrhosis | Hypertension, Portal
Boehringer Ingelheim

Recruiting

A Study to Test the Effect of BI 456906 on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)

Obesity

New Zealand, United States, Canada
Boehringer Ingelheim

Not yet recruiting

DAREONᵀᴹ-8: A Study to Test How Well Different Doses of BI 764532 in Addition to Standard of Care Are Tolerated by People With Advanced Small Cell Lung Cancer (DAREONᵀᴹ-8)

Small Cell Lung Carcinoma (SCLC)
Boehringer Ingelheim

Not yet recruiting

A Study in Healthy People to Test Whether Iclepertin Has an Effect on Cardiac Safety

Healthy
Boehringer Ingelheim

Recruiting

A Study in Healthy Men to Test Whether BI 1015550 Influences the Amount of Nintedanib and Pirfenidone in the Blood

Healthy

Germany
Click Therapeutics, Inc.

Recruiting

An Extension Study of a Second Course of a Digital Therapeutic for the Treatment of Experiential Negative Symptoms of Schizophrenia

Schizophrenia | Negative Symptoms in Schizophrenia

United States
Boehringer Ingelheim

Recruiting

A Study to Test Whether BI 456906 Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight (SYNCHRONIZE™-2)

Obesity | Diabetes Mellitus, Type 2

United States, Canada, New Zealand
Boehringer Ingelheim

Recruiting

A Study to Test Whether BI 456906 Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose Weight (SYNCHRONIZE™-1)

Obesity

United States, Canada, New Zealand
Boehringer Ingelheim

Recruiting

A Study to Test How Well Different Doses of BI 3706674 Are Tolerated by People With Advanced Cancer in the Stomach and Oesophagus

Solid Tumor, KRAS Mutation

United States
Boehringer Ingelheim

Not yet recruiting

Brightline-4: A Study to Test How Well Brigimadlin is Tolerated by People With a Type of Cancer Called Dedifferentiated Liposarcoma

Liposarcoma, Dedifferentiated
University of Alberta

Not yet recruiting

Ambulatory Oxygen Therapy for Individuals With Mild-to-moderate Interstitial Lung Disease

Fibrotic Interstitial Lung Disease
Boehringer Ingelheim

Recruiting

A Study to Test Whether Spesolimab Helps People With Generalized Pustular Psoriasis Who Need Treatment for Repeated Flares

Generalized Pustular Psoriasis

Australia, Spain, Belgium, China, Singapore, Malaysia, Taiwan, Thailand, Korea, Republic of, France
Boehringer Ingelheim

Recruiting

A Study to Test How Well Different Doses of BI 771716 Are Tolerated by People With an Advanced Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy

Geographic Atrophy

United States
Boehringer Ingelheim

Recruiting

A Study to Test How Well Different Doses of BI 1584862 Are Tolerated by Healthy Men

Healthy

Germany
Boehringer Ingelheim

Recruiting

A Study in Healthy People to Test How Well Repeated Doses of BI 3032950 Are Tolerated

Healthy

Belgium
Boehringer Ingelheim

Not yet recruiting

DAREON™-9: A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With Small Cell Lung Cancer When Taken Together With Topotecan

Small Cell Lung Carcinoma (SCLC)
Boehringer Ingelheim

Recruiting

A Study to Test How Well Different Doses of BI 3006337 Are Tolerated by People With Overweight or Obesity and With Fatty Liver Disease

Obesity | Non-alcoholic Fatty Liver Disease

United States
Boehringer Ingelheim

Recruiting

A Study in the United Sates That Looks at the Safety and Effectiveness of Pradaxa Pellets in Children Aged 3 Months to Less Than 12 Years Who Need Treatment of a Blood Clot or Who Have Had a Blood Clot and Are at Risk of Developing Another Blood Clot

Venous Thromboembolism

United States
Boehringer Ingelheim

Not yet recruiting

A Study to Test How BI 764532 is Taken up by Tumours in People With Small-cell Lung Cancer or Neuroendocrine Cancer

Neuroendocrine Neoplasms | Small Cell Lung Carcinoma (SCLC)
Boehringer Ingelheim

Recruiting

A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood

Healthy

Germany
Boehringer Ingelheim

Not yet recruiting

A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With a Tumour in the Brain That is Positive for DLL3

Glioma
Boehringer Ingelheim

Not yet recruiting

Natural History of Netherton Syndrome

Netherton Syndrome
Boehringer Ingelheim

Not yet recruiting

A Study in Women With Overweight or Obesity to Test Whether Different Doses of BI 456906 Influence the Amount of a Contraceptive in the Blood

Healthy
Boehringer Ingelheim

Recruiting

DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers

Small Cell Lung Carcinoma | Neuroendocrine Neoplasms

United States, Spain, Korea, Republic of, Germany, Japan, China, Belgium
Boehringer Ingelheim

Not yet recruiting

Non-interventional Study (NIS) on Sodium-glucose Co-transporter-2 Inhibitors (SGLT2i) Use in France

Diabetes Mellitus, Type 2
Boehringer Ingelheim

Recruiting

A Study to Test How Well Different Doses of BI 764532 in Combination With Ezabenlimab Are Tolerated by People With Small Cell Lung Cancer and Other Neuroendocrine Tumours That Are Positive for DLL3

Neuroendocrine Neoplasms | Small Cell Lung Carcinoma (SCLC)

Germany, Belgium, Japan, France
Boehringer Ingelheim

Not yet recruiting

A Study to Test How Well BI 1291583 is Tolerated by People With Cystic Fibrosis Bronchiectasis (Clairafly™)

Bronchiectasis | Cystic Fibrosis
Boehringer Ingelheim

Recruiting

A Study to Test How Well Different Doses of BI 1815368 Are Tolerated by Healthy Men

Healthy

Belgium
Boehringer Ingelheim

Recruiting

A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Netherton Syndrome

Netherton Syndrome

United States, Belgium, Australia, Germany, China, Malaysia, Japan, France, Israel, Bulgaria, Italy, Switzerland, Portugal, Austria
Boehringer Ingelheim

Recruiting

Developing a Screening Tool for Interstitial Lung Disease in People With Rheumatoid Arthritis Using Risk Factors

Arthritis, Rheumatoid | Lung Diseases, Interstitial

United States, France
Boehringer Ingelheim

Recruiting

Clairleafᵀᴹ: A Study to Test Long-term Treatment With BI 1291583 in People With Bronchiectasis Who Took Part in a Previous Study With This Medicine

Bronchiectasis

Denmark, Germany, United States, Bulgaria, Canada, Korea, Republic of, Latvia, Netherlands
Amal Therapeutics

Recruiting

A Study to Evaluate ATP150/ATP152, VSV-GP154 and Ezabenlimab in Patients With KRAS G12D/G12V Mutated PDAC (KISIMA-02)

Pancreatic Ductal Adenocarcinoma

United States
Boehringer Ingelheim

Recruiting

A Study to Find a Suitable Dose of BI 1821736 and Test Whether it Helps People With Advanced Cancer

Solid Tumors

Spain, United States, Sweden
Click Therapeutics, Inc.

Recruiting

Study of Two Digital Therapeutics for the Treatment of Experiential Negative Symptoms of Schizophrenia (CONVOKE)

Schizophrenia

United States
LUNGevity Foundation

Recruiting

Project PEER: Understanding the Lung Cancer Patient ExperiEnce in the Real-World Setting (PEER)

Caregivers | Lung Cancer Patients

United States
Boehringer Ingelheim

Recruiting

Lunsayil 1: A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa

Hidradenitis Suppurativa

United States, Korea, Republic of, Spain, Israel, Australia, Japan, Germany, Belgium, Lithuania, Canada, Malaysia, Singapore, New Zealand, France, Netherlands and more

X